Study Title | LINES: European Low and Intermediate Risk Neuroblastoma – A SIOPEN Study |
---|---|
Protocol ID | LINES |
Disease (Sub Disease) | Neuroblastoma |
Diagnosis Stage | New diagnosis |
Location | NSW / VIC / WA |
Sponsor | Australian and New Zealand Children's Haematology Oncology Group/ |
Collaborators | Instituto de Investigacion Sanitaria La Fe |
Links | https://clinicaltrials.gov/ct2/show/NCT01728155 |
Trial Status | Closed to Recruitment |
Trial Open Date | 31/05/2019 |
Sites | John Hunter Children's Hospital / Monash Children's Hospital / Sydney Children's Hospital / Perth Children's Hospital |
Study Type | Treatment |
Phase | Phase 3 |
Age Eligibility | 90 days to 18 Years |
International registry ID's | NCT01728155 |